Davide Prosperi

7.2k total citations · 2 hit papers
153 papers, 5.6k citations indexed

About

Davide Prosperi is a scholar working on Molecular Biology, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Davide Prosperi has authored 153 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 50 papers in Biomaterials and 28 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Davide Prosperi's work include Nanoparticle-Based Drug Delivery (45 papers), Advanced biosensing and bioanalysis techniques (32 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). Davide Prosperi is often cited by papers focused on Nanoparticle-Based Drug Delivery (45 papers), Advanced biosensing and bioanalysis techniques (32 papers) and Monoclonal and Polyclonal Antibodies Research (24 papers). Davide Prosperi collaborates with scholars based in Italy, United States and Spain. Davide Prosperi's co-authors include Miriam Colombo, Fabio Corsi, Wolfgang J. Parak, Serena Mazzucchelli, M. P. Morales, Susana Carregal‐Romero, Johannes T. Heverhagen, Ingrid Böhm, Lucía Gutiérrez and Maria Francesca Casula and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Davide Prosperi

148 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biological applications of magnetic nanoparticles

2012 1.0k citations Miriam Colombo, Davide Prosperi et al. profile →
The emerging role of nanotechnology in skincare

2021 188 citations Lucia Salvioni, Lucia Morelli et al. profile →

Peers

Countries citing papers authored by Davide Prosperi

Since Specialization

Citations

This map shows the geographic impact of Davide Prosperi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Prosperi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Prosperi more than expected).

Fields of papers citing papers by Davide Prosperi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Prosperi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Prosperi. The network helps show where Davide Prosperi may publish in the future.

Co-authorship network of co-authors of Davide Prosperi

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Prosperi. A scholar is included among the top collaborators of Davide Prosperi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Prosperi. Davide Prosperi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Microplastics in Cosmetics: Open Questions and Sustainable Opportunities 2024 ·ChemSusChem ·(unknown), (unknown), (unknown), (unknown), Lucia Morelli, (unknown), (unknown), Paolo Galli, Davide Prosperi, Miriam Colombo	15
2	Advanced Cell Culture Models Illuminate the Interplay between Mammary Tumor Cells and Activated Fibroblasts 2023 ·Cancers ·(unknown), Alessandro Colombo, (unknown), (unknown), (unknown), Metello Innocenti, Davide Prosperi, Miriam Colombo, Luisa Fiandra	7
3	Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells 2022 ·iScience ·Miriam Colombo, Laura Marongiu, Francesca Mingozzi, Roberta Marzi, (unknown), Fabio A. Facchini, (unknown), (unknown), (unknown), (unknown), (unknown), Maria Antonietta Rizzuto, Lucia Salvioni, Ivan Zanoni, Alessandro Gori, Davide Prosperi, Francesca Granucci	8
4	Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells 2022 ·Pharmaceutics ·Lucia Salvioni, (unknown), (unknown), (unknown), Jessica Bertolini, (unknown), Paolo Tortora, Davide Prosperi, Miriam Colombo	2
5	Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax 2021 ·Cells ·Leopoldo Sitia, Arianna Bonizzi, Serena Mazzucchelli, Sara Negri, Cristina Sottani, Elena Grignani, Maria Antonietta Rizzuto, Davide Prosperi, Luca Sorrentino, Carlo Morasso, Raffaele Allevi, Marta Sevieri, (unknown), Marta Truffi, Fabio Corsi	41
6	Impact of Tuning the Surface Charge Distribution on Colloidal Iron Oxide Nanoparticle Toxicity Investigated in Caenorhabditis elegans 2021 ·Nanomaterials ·(unknown), Lucia Salvioni, (unknown), (unknown), (unknown), Paolo Tortora, Davide Prosperi, Miriam Colombo, Maria Elena Regonesi	9
7	Evaluation of TFR-1 Expression in Feline Mammary Cancer and In Vitro Antitumor Efficacy Study of Doxorubicin-Loaded H-Ferritin Nanocages 2021 ·Cancers ·(unknown), Alessandro Sammarco, (unknown), (unknown), (unknown), Davide Prosperi, Maria Antonietta Rizzuto, Michela Bellini, Raffaella De Maria, Federico Bonsembiante, Silvia Ferro, (unknown), Valentina Zappulli, Laura Cavicchioli	0
8	Relaxometric Studies of Gd-Chelate Conjugated on the Surface of Differently Shaped Gold Nanoparticles 2020 ·Nanomaterials ·(unknown), Rachele Stefanìa, Carla Carrera, (unknown), Daniela Delli Castelli, Simona Baroni, Miriam Colombo, Davide Prosperi, Silvio Aime	7
9	MnO Nanoparticles Embedded in Functional Polymers as T₁ Contrast Agents for Magnetic Resonance Imaging 2020 ·ACS Applied Nano Materials ·Michele Mauri, Veronica Collico, Lucia Morelli, Pradip Das, Isabel Garcı́a, (unknown), Michela Bellini, (unknown), Marta Truffi, Fabio Corsi, Roberto Simonutti, Luis M. Liz‐Marzán, Miriam Colombo, Davide Prosperi	37
10	<p>Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease</p> 2020 ·International Journal of Nanomedicine ·Marta Truffi, Marta Sevieri, Lucia Morelli, Matteo Monieri, Serena Mazzucchelli, Luca Sorrentino, Raffaele Allevi, Arianna Bonizzi, Pietro Zerbi, (unknown), Erika Longhi, Gianluca M. Sampietro, F. Colombo, Davide Prosperi, Miriam Colombo, Fabio Corsi	15
11	Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model 2020 ·Scientific Reports ·Francesco Andreata, Arianna Bonizzi, Marta Sevieri, Marta Truffi, Matteo Monieri, Leopoldo Sitia, (unknown), Luca Sorrentino, Raffaele Allevi, Pietro Zerbi, (unknown), Erika Longhi, Roberta Ottria, Sara Casati, Renzo Vanna, Carlo Morasso, Melissa Bellini, Davide Prosperi, Fabio Corsi, Serena Mazzucchelli	19
12	Monitoring the Fate of Orally Administered PLGA Nanoformulation for Local Delivery of Therapeutic Drugs 2019 ·Pharmaceutics ·Lucia Morelli, Sara Gimondi, Marta Sevieri, Lucia Salvioni, (unknown), Barbara Colzani, Luca Palugan, Anastasia Foppoli, Laura Talamini, Lavinia Morosi, Massimo Zucchetti, Martina Bruna Violatto, (unknown), Mario Salmona, Davide Prosperi, Miriam Colombo, Paolo Bigini	29
13	Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles 2018 ·International Journal of Nanomedicine ·Barbara Colzani, Laura Pandolfi, (unknown), (unknown), Antonino Natalello, Svetlana Avvakumova, Miriam Colombo, Davide Prosperi	59
14	Innovative approach to safely induce controlled lipolysis by superparamagnetic iron oxide nanoparticles-mediated hyperthermic treatment 2017 ·The International Journal of Biochemistry & Cell Biology ·(unknown), Laura Pandolfi, Manuela Malatesta, Miriam Colombo, Veronica Collico, (unknown), Stefano Tambalo, (unknown), (unknown), Federico Boschi, Silvia Mannucci, Andrea Sbarbati, Davide Prosperi, Laura Calderan	21
15	Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity 2016 ·Oncotarget ·Serena Mazzucchelli, Michela Bellini, Luisa Fiandra, Marta Truffi, Maria Antonietta Rizzuto, Luca Sorrentino, Erika Longhi, Manuela Nebuloni, Davide Prosperi, Fabio Corsi	44
16	Stem Cell-Mediated Exon Skipping of the Dystrophin Gene by the Bystander Effect 2015 ·Current Gene Therapy ·Mirella Meregalli, Andrea Farini, Clementina Sitzia, Cyriaque Beley, P. Razini, Letizia Cassinelli, F. Colleoni, (unknown), Nadia Santo, Elisabetta Galbiati, Davide Prosperi, Alessandro Tavelli, M. Belicchi, Luis García, Yvan Torrente	1
17	Biotechnological approaches toward nanoparticle biofunctionalization 2013 ·Trends in biotechnology ·Svetlana Avvakumova, Miriam Colombo, Paolo Tortora, Davide Prosperi	100
18	Dependence of nanoparticle-cell recognition efficiency on the surface orientation of scFv targeting ligands 2013 ·Biomaterials Science ·Serena Mazzucchelli, Silvia Sommaruga, (unknown), Patrizia Galeffi, Paolo Tortora, Davide Prosperi, Miriam Colombo	19
19	Site‐Specific Conjugation of ScFvs Antibodies to Nanoparticles by Bioorthogonal Strain‐Promoted Alkyne–Nitrone Cycloaddition 2011 ·Angewandte Chemie International Edition ·Miriam Colombo, Silvia Sommaruga, Serena Mazzucchelli, Laura Polito, Paolo Verderio, Patrizia Galeffi, Fabio Corsi, Paolo Tortora, Davide Prosperi	58
20	Phantom Nanoparticles as Probes of Biomolecular Interactions 2006 ·Small ·Davide Prosperi, Carlo Morasso, Francesco Mantegazza, Marco Buscaglia, Loren E. Hough, Tommaso Bellini	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact